Bionano Genomics Announces Six User Presentations of OGM Results in Cancer Genomics Research at the Spanish Society of Hematology (SEHH) 2022
October 06, 2022 08:00 ET
|
Bionano Genomics
SAN DIEGO, Oct. 06, 2022 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced its participation at the Spanish Society of Hematology (SEHH) 2022 Conference, with six scientific...
Bionano Genomics Announces Publication of Study from Sorbonne Université Showing that WGS Identified only 63% of Structural Variations that OGM Detected in Liver Cancer
October 04, 2022 08:00 ET
|
Bionano Genomics
SAN DIEGO, Oct. 04, 2022 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced the publication of a study showing the use of optical genome mapping (OGM) to investigate a...
Bionano Laboratories to Provide Enhanced Genetic Counseling and Patient Care for Genetic Disorders with OptraHEALTH’s HealthFAX™
September 26, 2022 08:00 ET
|
Bionano Genomics
SAN DIEGO and SAN JOSE, Sept. 26, 2022 (GLOBE NEWSWIRE) -- Bionano Laboratories and OptraHEALTH today announced their collaboration to utilize HealthFAX’s proprietary AI platform to enhance genetic...
Bionano Genomics Announces Launch of CLIA-Certified Bionano Laboratories, and Expands its Clinical Testing Menu with Launch of First OGM-Based LDT for FSHD
September 23, 2022 08:00 ET
|
Bionano Genomics
SAN DIEGO, Sept. 23, 2022 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced the launch of Bionano Laboratories, a new organization that combines Bionano’s optical genome...
Bionano Genomics Announces Publication of Study Using OGM for Detection of Balanced Chromosomal Rearrangements Found in Recurrent Pregnancy Loss
September 21, 2022 08:00 ET
|
Bionano Genomics
SAN DIEGO, Sept. 21, 2022 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced the publication of a study utilizing OGM to detect cryptic balanced chromosomal rearrangements...
Bionano Genomics Announces Publication of Study in MDS and AML Showing Utility for Refined Diagnostics and Prognostic Stratification
September 14, 2022 08:00 ET
|
Bionano Genomics
SAN DIEGO, Sept. 14, 2022 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced the publication of a study evaluating the performance of OGM for detection of cytogenetic...
Bionano Genomics Announces Publication of Study Demonstrating Utility of OGM as Part of a Comprehensive Workflow for Quality Evaluation of Human Induced Pluripotent Stem Cells (iPSCs)
September 08, 2022 08:00 ET
|
Bionano Genomics
SAN DIEGO, Sept. 08, 2022 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO), today announced the publication of a study demonstrating the utility of optical genome mapping (OGM) as part of a...
Bionano Genomics to Participate at the H.C. Wainwright 24th Annual Global Investment Conference
September 07, 2022 16:30 ET
|
Bionano Genomics
SAN DIEGO, Sept. 07, 2022 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (BNGO) announced today that company management will participate virtually at the H.C. Wainwright 24th Annual Global Annual Global...
Bionano Genomics Announces the First Publication Using OGM to Analyze Impact of Chromothripsis and TP53 Abnormalities on Chronic Lymphocytic Leukemia (CLL) Patients with High Genomic Complexity
August 25, 2022 08:00 ET
|
Bionano Genomics
SAN DIEGO, Aug. 25, 2022 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced the publication of the first study to use optical genome mapping (OGM) to analyze the impact of...
Bionano Genomics Announces First Publication Using OGM for Detection of Repeat Expansions in CANVAS and Adult-Onset Ataxia
August 11, 2022 08:00 ET
|
Bionano Genomics
SAN DIEGO, Aug. 11, 2022 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced the publication of the first study to evaluate the utility of optical genome mapping (OGM) in the...